Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Indian firms sign customers

January 9, 2006 | A version of this story appeared in Volume 84, Issue 2

Nicholas Piramal has signed a seven-year manufacturing and R&D services agreement with Pfizer. The Mumbai-based custom chemical firm will provide process development and scale-up services to Pfizer's animal health business. Separately, Uttar Pradesh-based Jubilant Organosys has signed a five-year contract to provide Eli Lilly & Co. with a range of drug discovery services. Both Jubilant and Piramal have in the past claimed that the world's largest drug companies were among their customers but that confidentiality agreements prevented them from being more specific.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.